Skip to main content
. 2021 May 20;9(5):580. doi: 10.3390/biomedicines9050580

Table 1.

Results of NTA and DLS analysis, calculated concentrations of EV-enriched and fc fractions from control and cancer patient samples designated as Pool A and Pool B.

Particle Number from NTA (109/mL) Approximated Diameter (nm) Approximated Concentration (mg/mL)
Sample Control Pool A Pool B Control Pool A Pool B
EV5 414 978 3029 500 27 63 197
EV12 1494 3206 16,332 200 6.3 13 69
EV120 960 2014 2817 100 0.5 1.0 1.4
fc 1116 2235 662 <50 0.07 0.15 0.04